FACULTY:
Sheldon Gross, MD, is an Associate Professor and Specialist with the Department of Pediatrics at UT Health San Antonio. He is board certified in both pediatrics as well as neurology with special competence in child neurology with over 40-years experience in private practice.
OVERVIEW:
Pediatrics Now host Holly Wayment talks more with Dr. Sheldon Gross about evaluation and management of tics and Tourette's syndrome, plus when psychiatry and neurology in general overlap.
This episode also covers related conditions—PANDAS/PANS, autoimmune encephalitis, functional neurological disorders, and seizures—highlighting collaboration between specialties and offering reassurance about prognosis for most children.
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Speaker: Sheldon Gross, MD has no financial relationships with ineligible companies to disclose.
The Pediatrics Now Podcast Planning Committee members: Steven Seidner, MD, and Holly Wayment have no financial relationships with ineligible companies to disclose.
The University of Texas at San Antonio and Steven Seidner, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas at San Antonio designates this live activity up to a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
11/21/2025
EXPIRATION DATE:
8/31/2028